Lymphoma is the third common malignancy of childhood, presenting with rapidly or slowly growing mass, systemic B symptoms (fever, night sweats and weight loss), hepatomegaly and splenomegaly. Here, we report an eight year old male child who presented with fever, dyspnoea and weight loss of three kilograms over the last month; had right pleural effusion and was investigated for both infectious and non-infectious causes and later was diagnosed as Non-Hodgkin lymphoma. It emphasizes the importance of high suspicion, especially in the presence of haemorrhagic pleural fl uid, to differentiate it from other common causes of pleural effusion in childhood.
Teaching Hospital with fever since fi ve days and acute onset of MRC grade III dyspnea (The Modifi ed Borg scale) 3 for three days. He also had history of weight loss of three kg over last one month. His development was appropriate for age and he had no signifi cant illness in past. He was born out of non-consanguineous marriage with uneventful birth history and a negative family history of malignancy. On detailed examination, the child was malnourished (Protein energy malnutrition Grade II as per Indian Academy of Paediatrics Classifi cation based on weight for age) with Tanner stage I. The child was tachypnoeic and with oxygen saturation of 94% in room air. He had palpable lymph nodes in central axilla and right inguinal region with a size of 0.5 cm × 0.5 cm, which was single, fi rm, non-tender and fi xed. On respiratory examination, there was decreased chest movement on right side, along with marked dullness on percussion, decreased vocal resonance and breath sound over the right chest. Other systemic examination revealed no abnormality.
On investigations, Chest-X-ray showed right sided pleural effusion. Erythrocyte sedimentation rate (33 mm/1 st hour) and lactate dehydrogenase (LDH: 1332 U/L) was high while haemoglobin, complete blood count, renal and liver function tests, and peripheral blood smear were normal. Pleural fl uid analysis revealed haemorrhagic fl uid with low sugar (4 mg/dl), high protein (5.5 g/dl), high total count (32,200/mm INTRODUCTION L ymphoma, being the third most common malignancy is still rare with incidence of 11% of childhood cancer, and is twice common in boys than girls 1 . There are two main types of lymphoma: Hodgkin lymphoma and non-Hodgkin lymphoma (NHL). NHL accounts for more than half (53%) of all lymphomas in children 1 . The incidence of NHL in Nepal is not known as there is no national population based cancer registry, but NHL stands as the fourth common malignancy and comprises almost eight percent of childhood cancer in Kanti Children Hospital 2 . It presents either as a rapidly growing mass or systemic B symptoms (fever, night sweats and weight loss) or slowly growing lymphadenopathy, hepatomegaly or splenomegaly. Other presentations include skin rash, pruritus, pyrexia of unknown origin, ascites and pleural effusion. Here we are discussing a child with haemorrhagic pleural effusion who was later diagnosed as NHL. 5, 6, 7 . Child hood non-Hodgkin lymphomas can be classifi ed as one of the following types The incidence of Burkitt lymphoma is higher (38%) in children between 0-14 years of age whereas diffuse large B cell lymphoma (DLBCL) is higher (39%) in children between 15-19 years of age 8 .
CASE REPORT
The clinical manifestations of NHL in childhood and adolescent depend on site of involvement (primary or secondary) or on pathological subtype. Most of the patients with NHL are diagnosed late with advanced disease at stage III or IV, including extra-nodal disease with gastrointestinal, bone marrow and CNS involvement. Our patient was diagnosed as a lymphoblastic lymphoma (stage III as per St. Jude staging system 7 for childhood Non-Hodgkin Lymphoma) with high Lactate dehydrogenase (1332 IU/l) without any involvement of CNS and bone marrow. There is unfavourable prognosis if age at diagnosis is late (i.e. the older paediatric patient: adolescent or young adult have poorer prognosis), involvement of CNS and bone marrow, and the serum level of lactate dehydrogenase is more than 1000 IU/L 9, 10 . Lymp hoblastic lymphoma comprises approximately 20% of childhood NHL, and often presents with intrathoracic or mediastinal involvement as an anterior mediastinal mass (75%) 11 . It may manifest as dyspnoea, wheezing, stridor, dysphagia, or swelling of the head and neck. The frequency of pleural effusions is 20% in NHL which has unclear prognostic implication 12 . The pr imary pathogenesis of pleural effusion is due to the direct pleural infi ltration in NHL . Lymphoblastic lymphoma may also involve bone, skin, bone marrow, central nervous system, abdominal organs (but rarely bowel), and occasionally other sites such as lymphoid tissue of Waldeyer ring and testes. As soon as the diagnosis of NHL is suspected, immediate assessment and stabilization of the patient's metabolic status is necessary with rehydration of child with 3000 ml/m2/day with 5% dextrose in 0.25% isotonic saline intravenously without supplementary potassium to prevent tumour lysis syndrome which results in hyperkalaemia, hyperuricaemia, and hyperphosphataemia 10 . This is followed by addition of sodium bicarbonate to maintain alkaline urine (pH 7-7.4) for 24-48 hours and [Xanthine oxidase inhibitors: Allopurinol (10 mg/kg/day, divided into two to three doses) 10 . But the primary modality of treatment for childhood and adolescent NHL is multi-agent systemic chemotherapy with intrathecal chemotherapy 7 . Surgery is used mainly for diagnosis and staging. Systemic chemotherapy includes acute lymphoblastic leukaemia regimens like eight drug induction (Corticosteroid, vincristin, daunorubicin, asparaginase, cyclophosphamide, cytarabine, 6-mercaptopurine and intrathecal methotrexate) therapy and a consolidation (6-mercaptopurine, high-dose methotrexate, intrathecal methotrexate) and re-intensifi cation (dexamethasone, vincristin, doxorubicin, asparaginase, cyclophosphamide, cytarabine, thioguanine and intrathecal methotrexate) therapy, which is followed by maintenance therapy (6-mercaptopurine and oral methotrexate) for a total therapy duration of 24 months .
CONCLUSION
The burden of acute infectious disease in the developing countries is still heavy, but this does not exclude the need to identify rare malignancies. A high degree of suspicion, especially in the presence of haemorrhagic pleural fl uid, is required to differentiate it from other common causes of pleural effusion in childhood. Its early diagnosis and management are important to prevent further complications of the disease.
